Loading...
OTCM
ANSLY
Market cap4.42bUSD
Oct 08, Last price  
124.00USD
1D
0.00%
1Q
47.46%
Jan 2017
74.21%
Name

Ansell Ltd

Chart & performance

D1W1MN
OTCM:ANSLY chart
P/E
20.47
P/S
2.00
EPS
1.51
Div yield, %
1.63%
Shrs. gr., 5y
2.02%
Rev. gr., 5y
1.53%
Revenues
2.19b
+9.18%
1,051,060,2201,190,861,1661,080,923,5001,037,119,9401,303,678,6861,261,450,0531,222,884,0001,590,200,0001,645,100,0001,352,800,0001,374,500,0001,489,800,0001,499,000,0001,613,700,0002,026,900,0001,952,100,0001,655,100,0001,619,300,0002,003,300,0002,187,187,611
Net income
213m
+109.82%
71,882,91598,162,00078,325,98285,520,677140,253,862134,604,032124,844,00041,800,000187,500,000159,100,000147,700,000484,300,000111,700,000158,700,000246,700,000158,700,000148,300,00076,500,000101,600,000213,179,765
CFO
355m
+48.40%
116,954,448156,009,88594,813,643160,801,628138,075,24796,318,457109,350,604220,306,946162,624,620232,300,000197,827,993153,600,000188,900,000286,700,000172,800,000222,000,000180,500,000272,300,000239,300,000355,129,284
Dividend
Sep 03, 20261.64713 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ansell Limited, an Australian company established in Richmond in 1893, is a global leader in the innovation, development, and production of protective equipment. Active across numerous regions including the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America, the company operates through two core divisions. It was previously known as Pacific Dunlop Limited, changing its name to Ansell Limited in 2002. P. D. Holdings Pty. Ltd. is a current subsidiary. Its Healthcare segment specializes in manufacturing and distributing a broad range of protective items such as surgical, examination, single-use, and sterile gloves, as well as specialized apparel and consumables. These products serve various medical and scientific settings, including hospitals, surgical facilities, dental practices, veterinary clinics, emergency services, laboratories, and pharmaceutical and life sciences organizations. The Industrial segment focuses on crafting and supplying protective solutions for hands and against chemical hazards. These products are essential for a diverse array of industrial applications, spanning automotive, chemical, metal fabrication, machinery and equipment, food processing, construction, mining, oil and gas, and first responder activities.

Related entities

Subsidiaries (2)
ANSELL LIQUID ASSET HOLDINGS LLC
ANSELL HEALTHCARE EUROPE

Key people

Non-Executive Independent Chairman of the Board · since 2019
Darryl Nazareth
President of the Healthcare Global Business Unit · since 2019
Neil I. Salmon
President of Industrial Global Business Unit · since 2019
Debbie Lynch
Chief Human Resource Officer
Amanda Manzoni
Chief Human Resource Officer
Peter Dobbelsteijn
Senior Vice President - Global Supply Chain and Ansell Global Guardian · since 2017
John Marsden
Senior Vice President of Global Operations and R&D · since 2019
Giri Peddinti
Senior Vice President, Global Chief Information Officer · since 2012
Jocelyn Petersen
Vice President - Global FP&A,
Chief Executive Officer, Managing Director, Executive Director · since 2010
Francois Le Jeune
Senior Vice President - Business Development, Transformation and Corporate Marketing · since 2017
Augusto Accorsi
SBU Vice President & GM, HGBU Exam & Single Use
Paul Bryce
SBU Vice President & GM, IGBU Chemical Solution
Rikard Froberg
Chief Commercial Officer - EMEA & APAC
Frederic Guyonneau
SBU Vice President & GM, HGBU Life Sciences
Angie Phillips
SBU Vice President & GM, HGBU Surgical & HSS
Catherine Stribley
Company Secretary · since 2017
William G. Reilly
Non-Executive Director · since 2017
William Peter Day
Non-Executive Independent Director · since 2007
Leslie A. Desjardins
Non-Executive Independent Director · since 2015
IPO date
Jan 02, 1981
Employees
14,000
Domiciled in
AU
Incorporated in
AU
Legal address
678 VICTORIA STREET
RICHMOND, VIC 3121
AU
Headquarters
VICTORIA GARDENS, 678 VICTORIA STREET
RICHMOND, VIC 3121
AU

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT